[HTML][HTML] SARS-CoV-2 501Y. V2 escapes neutralization by South African COVID-19 donor plasma
…, P Kgagudi, B Oosthuysen, BE Lambson… - Nature medicine, 2021 - nature.com
SARS-CoV-2 501Y.V2 (B.1.351), a novel lineage of coronavirus causing COVID-19, contains
substitutions in two immunodominant domains of the spike protein. Here, we show that …
substitutions in two immunodominant domains of the spike protein. Here, we show that …
Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape
…, NL Tumba, MR Abrahams, BE Lambson… - Nature medicine, 2012 - nature.com
Neutralizing antibodies are likely to play a crucial part in a preventative HIV-1 vaccine.
Although efforts to elicit broadly cross-neutralizing (BCN) antibodies by vaccination have been …
Although efforts to elicit broadly cross-neutralizing (BCN) antibodies by vaccination have been …
[HTML][HTML] Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection
…, N Ranchobe, BE Lambson, ES Gray, E Cave… - PLoS …, 2009 - journals.plos.org
We previously showed that HIV-1 subtype C viruses elicit potent but highly type-specific
neutralizing antibodies (nAb) within the first year of infection. In order to determine the specificity …
neutralizing antibodies (nAb) within the first year of infection. In order to determine the specificity …
[HTML][HTML] Cross-reactive neutralizing antibody responses elicited by SARS-CoV-2 501Y. V2 (B. 1.351)
…, D Mhlanga, B Oosthuysen, BE Lambson… - … England Journal of …, 2021 - Mass Medical Soc
Cross-Reactive Antibody Responses Elicited by the 501Y.V2 Variant Convalescent serum
from persons who had recovered from infection with 501Y.V2 (B.1.351), a SARS-CoV-2 …
from persons who had recovered from infection with 501Y.V2 (B.1.351), a SARS-CoV-2 …
[HTML][HTML] Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin
Griffithsin (GRFT), Cyanovirin-N (CV-N) and Scytovirin (SVN) are lectins that inhibit HIV-1
infection by binding to multiple mannose-rich glycans on the HIV-1 envelope glycoproteins (…
infection by binding to multiple mannose-rich glycans on the HIV-1 envelope glycoproteins (…
[PDF][PDF] SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals
…, NP Manamela, MA van der Mescht, BE Lambson… - Cell Host & Microbe, 2022 - cell.com
The SARS-CoV-2 Omicron variant escapes neutralizing antibodies elicited by vaccines or
infection. However, whether Omicron triggers cross-reactive humoral responses to other …
infection. However, whether Omicron triggers cross-reactive humoral responses to other …
Ability to develop broadly neutralizing HIV-1 antibodies is not restricted by the germline Ig gene repertoire
C Scheepers, RK Shrestha, BE Lambson… - The Journal of …, 2015 - journals.aai.org
The human Ig repertoire is vast, producing billions of unique Abs from a limited number of
germline Ig genes. The IgH V region (IGHV) is central to Ag binding and consists of 48 …
germline Ig genes. The IgH V region (IGHV) is central to Ag binding and consists of 48 …
[HTML][HTML] IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody
SI Richardson, BE Lambson, AR Crowley… - PLoS …, 2019 - journals.plos.org
Broadly neutralizing antibodies (bNAbs) protect against HIV infection in non-human primates
and their efficacy may be enhanced through interaction with Fc receptors on immune cells. …
and their efficacy may be enhanced through interaction with Fc receptors on immune cells. …
Use of PCR To Detect Leishmania(Viannia) spp. in Dog Blood and Bone Marrow
R Reithinger, BE Lambson, DC Barker… - Journal of clinical …, 2000 - Am Soc Microbiol
A PCR-based protocol for the detection of Leishmania(Viannia) parasites in canine blood,
buffy coat, and bone marrow was developed and was then tested with field samples taken …
buffy coat, and bone marrow was developed and was then tested with field samples taken …
[HTML][HTML] SARS-CoV-2 501Y. V2 (B. 1.351) elicits cross-reactive neutralizing antibodies
…, F Ayres, D Mhlanga, B Oosthuysen, BE Lambson… - bioRxiv, 2021 - ncbi.nlm.nih.gov
Neutralization escape by SARS-CoV-2 variants, as has been observed in the 501Y. V2 (B.
1.351) variant, has impacted the efficacy of first generation COVID-19 vaccines. Here, the …
1.351) variant, has impacted the efficacy of first generation COVID-19 vaccines. Here, the …